Overview
Nanophyetus salmincola is a parasitic trematode that infects freshwater fish, particularly salmonids, and can cause significant morbidity and mortality in both fish populations and humans who consume undercooked infected fish. Human infections, known as salmon poisoning disease (SPD), are characterized by severe gastrointestinal symptoms, fever, and systemic effects due to the presence of secondary bacterial infections. SPD is primarily observed in coastal regions of the Pacific Northwest in North America, particularly among individuals who consume raw or undercooked fish from contaminated waters. Early recognition and prompt treatment are crucial in preventing severe complications and fatalities, making this knowledge essential for clinicians practicing in endemic areas. 13Pathophysiology
The lifecycle of Nanophyetus salmincola involves an intermediate host, typically a snail, and a definitive host, which is primarily fish. Humans become infected by consuming raw or undercooked fish harboring the metacercariae stage of the parasite. Once ingested, the metacercariae excyst in the human small intestine, releasing enzymes that facilitate their penetration into the intestinal mucosa. This invasion triggers an inflammatory response, leading to ulceration and hemorrhage. The primary clinical manifestation arises not from the parasite itself but from the subsequent bacterial translocation across the compromised intestinal barrier. Common secondary pathogens include Yersinia enterocolitica, Vibrio spp., and Campylobacter spp., which proliferate in the damaged intestinal environment, causing systemic symptoms and potential sepsis. The interplay between the parasitic invasion and subsequent bacterial infection drives the severity of SPD, highlighting the importance of both parasitic and infectious disease management strategies. 13Epidemiology
Nanophyetus salmincola infections are geographically restricted, predominantly affecting coastal regions of the Pacific Northwest in the United States, including Oregon and Washington. The incidence is relatively low but notable in communities with dietary practices involving raw fish consumption, such as the consumption of smoked or marinated fish. Epidemiological data suggest that the prevalence of SPD correlates with seasonal patterns, likely due to variations in fish parasite loads and human dietary habits. Risk factors include direct exposure to contaminated freshwater sources and cultural practices that involve raw fish consumption. There is limited longitudinal data, but trends indicate a stable incidence with occasional spikes following environmental changes that affect parasite prevalence in fish populations. 13Clinical Presentation
The clinical presentation of SPD typically includes an acute onset of symptoms within days of consuming contaminated fish. Common symptoms include severe abdominal pain, profuse watery diarrhea, vomiting, high fever, headache, and malaise. Patients may also exhibit signs of systemic toxicity, such as hypotension and altered mental status, especially if secondary bacterial infections progress to sepsis. Red-flag features include persistent high fever, significant dehydration, and signs of disseminated intravascular coagulation (DIC), which necessitate urgent medical intervention. Early recognition of these symptoms, particularly in endemic areas, is crucial for timely diagnosis and treatment. 13Diagnosis
Diagnosing SPD involves a combination of clinical suspicion, epidemiological context, and laboratory confirmation. The diagnostic approach typically includes:Differential Diagnosis:
Management
Initial Management
Specific Treatment
Contraindications:
Complications
Refer patients with signs of severe dehydration, sepsis, or DIC to critical care units for specialized management. 13
Prognosis & Follow-up
The prognosis for SPD is generally good with prompt and appropriate treatment, especially if secondary bacterial infections are managed effectively. Prognostic indicators include early recognition, timely initiation of supportive care, and targeted antibiotic therapy. Follow-up should include:Special Populations
Key Recommendations
References
1 Shukurov I, Mohamed MS, Mizuki T, Palaninathan V, Ukai T, Hanajiri T et al.. Biological Synthesis of Bioactive Gold Nanoparticles from . International journal of molecular sciences 2022. link 2 Abdelrahman EA, Alhamzani AG, Abou-Krisha MM, El-Sayyad GS, Abd El-Aziz SM. Assessing different extracts of Laurencia obtusa algae for the green fabrication of magnetic nanoparticles: their characterization and bioactivities. Food chemistry 2026. link 3 Lysik K, Maszczyk P, Zebrowski ML, Gozzo S, Lee JS, Pyznar M et al.. Temporal dynamics of lake microbiota under nanoplastic and enrofloxacin stress. The Science of the total environment 2026. link 4 Wu J, Xiong L, Yang Y, Li C, Mao P, Zhou Q et al.. Greenhouse gas emissions from black soldier fly composting of silver and silver sulfide nanoparticle-enriched sludge. Water research 2026. link 5 Kitiyodom S, Kamble MT, Yostawonkul J, Thompson KD, Pirarat N. Effectiveness of a new cationic lipid-based nanovaccine for enhancing immersion vaccination against Flavobacterium oreochromis in red tilapia (Oreochromis sp.). Fish & shellfish immunology 2025. link 6 Younis NS, El Semary NA, Mohamed ME. Silver nanoparticles green synthesis via cyanobacterium Phormidium sp.: characterization, wound healing, antioxidant, antibacterial, and anti-inflammatory activities. European review for medical and pharmacological sciences 2021. link